CLINICAL_TRIALS
trial_result
· 2016-02-22
Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease [Phase 3]
Summary
Phase 3 trial update for IPX066 in Parkinson's disease; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Impax Laboratories, LLC | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-02-22